REGISTERED NUMBER: 06174365 (England and Wales)

REPORT OF THE DIRECTORS AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

Optimum Rx Group Limited

Page

Company Information

1

Report of the Directors

2

Balance Sheet

4

Notes to the Financial Statements

6

Chartered Accountants' Report

10

DIRECTORS:

P D Bailey

M W Marland

REGISTERED OFFICE:

Unit 5 Newgate

White Lund Industrial Estate

Morecambe

Lancashire

LA3 3PT

REGISTERED NUMBER:

06174365 (England and Wales)

ACCOUNTANTS:

Langricks Limited

1 Swan Street

Wilmslow

Cheshire

SK9 1HF

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of a holding company.

Our Vision at Optimum is to enhance the quality of people's lives by continually developing and encouraging our team to push the boundaries of manufacturing techniques.

Optimum Rx Group is a well-regarded, independent ophthalmic lens manufacturing company.

On 28th March 2024 Optimum Rx Group Limited became employee owned through the creation of an Employee Ownership Trust (EOT) which purchased 100 per cent of the company's shares.

This transition highlights the company's commitment to recognising the invaluable contributions of its employees and ensuring long-term business stability. This new business structure ensures that every employee-owner shares in the rewards of their hard work and contributes to the company's future success. It promotes a culture of inclusivity and shared responsibility, where each employee's role is critical to the company's overall performance and sustainability.

This change is an incredible opportunity for growth and innovation. As an EOT company, we anticipate heightened employee engagement and productivity, resulting in even better service for our customers.

This move also guarantees the stability of the company, safeguarding the interests of both our employees and valued clients."

We are committed to the timely delivery of superior quality products and passionate about delivering exceptional customer care.

Our success is directly tied to our four core values which have become the cornerstones of our business: -

o Innovative: a dynamic workplace, inspiring growth and development.

o Passionate: about our people and our customers, driven to deliver excellence.

o Professional: providing outstanding products and the friendliest customer service in the industry.

o Ownership: as a team we all take personal responsibility for the continued success of our Company.

The average number of people employed by the group during the year was 2, all based at its well invested, state of the art manufacturing facility located in Morecambe, UK.

Optimum's broad product range, some of which is unavailable elsewhere in the UK market, is made through a number of innovative processes using an array of modern equipment. This ensures precise and high-quality products are consistently delivered at competitive prices with short lead times.

The business continues to expand and our continued investment in technology and the training and development of our people has positioned the business well for further growth.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

P D Bailey

M W Marland

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

P D Bailey - Director

30 October 2025

FIXED ASSETS

Tangible assets

4

-

-

Investments

5

1

1

1

1

CURRENT ASSETS

Debtors

6

119,123

166,285

Cash at bank

4,335

18,658

123,458

184,943

CREDITORS

Amounts falling due within one year

7

(28,783

)

(46,442

)

NET CURRENT ASSETS

94,675

138,501

TOTAL ASSETS LESS CURRENT LIABILITIES

94,676

138,502

CREDITORS

Amounts falling due after more than one year

8

-

(31,840

)

NET ASSETS

94,676

106,662

CAPITAL AND RESERVES

Called up share capital

833

833

Capital redemption reserve

167

167

Retained earnings

93,676

105,662

94,676

106,662

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 October 2025 and were signed on its behalf by:

P D Bailey - Director

1.	STATUTORY INFORMATION

Optimum Rx Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents management fees receivable net of VAT.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment 33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Investments in subsidiaries

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Financial instruments

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at

transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Debtors

Debtors do not carry any interest and are stated at their nominal value. Appropriate allowances for estimated irrecoverable amounts are recognised in the profit and loss account when there is objective evidence that the asset is impaired.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual

arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans , loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course o business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

17,171

Disposals

(17,171

)

At 31 March 2025

-

DEPRECIATION

At 1 April 2024

17,171

Eliminated on disposal

(17,171

)

At 31 March 2025

-

NET BOOK VALUE

At 31 March 2025

-

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 April 2024

and 31 March 2025

1

NET BOOK VALUE

At 31 March 2025

1

At 31 March 2024

1

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Amounts owed by group undertakings

118,123

164,000

Other debtors

1,000

2,285

119,123

166,285

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Taxation and social security

-

44,668

Other creditors

28,783

1,774

28,783

46,442

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Other creditors

-

31,840

9.	RELATED PARTY DISCLOSURES

Included within other debtors is an amount of £121,111 (2024: £164,000) due from Optimum Coatings Limited, a company of which the directors, PD Bailey and M Marland, were also directors during the year. Included within turnover is an amount of £nil (2024: £140,000) receivable from this company in relation to management charges.

10.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is the directors and shareholders of Optimum RX Group (EOT) Limited, and no individual controls the company.

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Optimum Rx Group Limited for the year ended 31 March 2025 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Optimum Rx Group Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Optimum Rx Group Limited and state those matters that we have agreed to state to the Board of Directors of Optimum Rx Group Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Optimum Rx Group Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Optimum Rx Group Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Optimum Rx Group Limited. You consider that Optimum Rx Group Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Optimum Rx Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Langricks Limited

1 Swan Street

Wilmslow

Cheshire

SK9 1HF

30 October 2025